ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Kiniksa Pharmaceuticals International PLC

Kiniksa Pharmaceuticals International PLC (KNSA)

22.61
0.45
(2.03%)
Closed March 15 3:00PM
18.1737
-4.44
(-19.62%)
After Hours: 6:51PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
18.1737
Bid
18.05
Ask
23.17
Volume
595,103
22.0201 Day's Range 22.86
16.56 52 Week Range 28.15
Market Cap
Previous Close
22.16
Open
22.36
Last Trade Time
Financial Volume
US$ 13,461,704
VWAP
22.6208
Average Volume (3m)
613,226
Shares Outstanding
72,644,240
Dividend Yield
-
PE Ratio
-37.99
Earnings Per Share (EPS)
-0.59
Revenue
423.24M
Net Profit
-43.19M

About Kiniksa Pharmaceuticals International PLC

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurre... Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
London, Gbr
Founded
-
Kiniksa Pharmaceuticals International PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KNSA. The last closing price for Kiniksa Pharmaceuticals was US$22.16. Over the last year, Kiniksa Pharmaceuticals shares have traded in a share price range of US$ 16.56 to US$ 28.15.

Kiniksa Pharmaceuticals currently has 72,644,240 shares outstanding. The market capitalization of Kiniksa Pharmaceuticals is US$1.61 billion. Kiniksa Pharmaceuticals has a price to earnings ratio (PE ratio) of -37.99.

KNSA Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3.0063-14.194050991521.1822.9418.173763774821.67202283CS
4-1.7463-8.7665662650619.9222.9418.173769995420.79273778CS
12-2.1563-10.606492867720.3322.9417.8261322620.11471225CS
26-7.2063-28.393617021325.3828.1517.8246872321.63440458CS
52-2.1363-10.518463810920.3128.1516.5643281421.57477534CS
1568.583789.50677789369.5928.157.3640386317.05470092CS
2600.07370.40718232044218.1337.3640217216.79459194CS

KNSA - Frequently Asked Questions (FAQ)

What is the current Kiniksa Pharmaceuticals share price?
The current share price of Kiniksa Pharmaceuticals is US$ 18.1737
How many Kiniksa Pharmaceuticals shares are in issue?
Kiniksa Pharmaceuticals has 72,644,240 shares in issue
What is the market cap of Kiniksa Pharmaceuticals?
The market capitalisation of Kiniksa Pharmaceuticals is USD 1.61B
What is the 1 year trading range for Kiniksa Pharmaceuticals share price?
Kiniksa Pharmaceuticals has traded in the range of US$ 16.56 to US$ 28.15 during the past year
What is the PE ratio of Kiniksa Pharmaceuticals?
The price to earnings ratio of Kiniksa Pharmaceuticals is -37.99
What is the cash to sales ratio of Kiniksa Pharmaceuticals?
The cash to sales ratio of Kiniksa Pharmaceuticals is 3.88
What is the reporting currency for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Kiniksa Pharmaceuticals?
The latest annual turnover of Kiniksa Pharmaceuticals is USD 423.24M
What is the latest annual profit for Kiniksa Pharmaceuticals?
The latest annual profit of Kiniksa Pharmaceuticals is USD -43.19M
What is the registered address of Kiniksa Pharmaceuticals?
The registered address for Kiniksa Pharmaceuticals is THIRD FLOOR, 23 OLD BOND STREET, LONDON, W1S 4PZ
What is the Kiniksa Pharmaceuticals website address?
The website address for Kiniksa Pharmaceuticals is www.kiniksa.com
Which industry sector does Kiniksa Pharmaceuticals operate in?
Kiniksa Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RDUSRadius Recycling Inc
US$ 27.902
(104.26%)
8.53M
BONBon Natural Life Ltd
US$ 1.40
(90.29%)
84M
SUNESUNation Energy Inc
US$ 0.5213
(62.96%)
513.96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255.00
(39.80%)
222
AAOIApplied Optoelectronics Inc
US$ 22.105
(39.29%)
17.01M
GLSTUGlobal Star Acquisition Inc
US$ 2.00
(-69.23%)
421
CURRCurrenc Group Inc
US$ 2.03
(-41.33%)
1.42M
ADTXAditxt Inc
US$ 0.0201
(-39.82%)
240.2M
HEPAHepion Pharmaceuticals Inc
US$ 0.0228
(-39.68%)
161.52M
WKSPWorksport Ltd
US$ 0.36205
(-35.45%)
4.96M
SUNESUNation Energy Inc
US$ 0.5213
(62.96%)
513.96M
NVDANVIDIA Corporation
US$ 121.67
(5.27%)
277.56M
ADTXAditxt Inc
US$ 0.0201
(-39.82%)
240.2M
HEPAHepion Pharmaceuticals Inc
US$ 0.0228
(-39.68%)
161.52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.225
(7.64%)
160.21M